Concepedia

Aslam Amod

AA

Statistics

Publications

13

Citations

991

H-Index

12

Active since

2001

Affiliations

University of KwaZulu-Natal(Current)

Novo Nordisk (Denmark)

University of Michigan

Translational Research Institute for Metabolism and Diabetes

Nelson Mandela Academic Hospital

Aslam Amod is an author at University of KwaZulu-Natal specializing in medicine, public health, and diabetes.

ORCID

Top concepts

Publications per year

2001–2023

13

Publications

13

Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial

Richard E. Pratley, Aslam Amod, Søren T. Hoff et al. · The Lancet · 2019 · 552 citations

, , +6

The 2012 SEMDSA Guideline for the Management of Type 2 Diabetes

Aslam Amod · Journal of Endocrinology Metabolism and Diabetes of South Africa · 2012 · 71 citations · Full text

, , +11

High incidence of Type 2 diabetes mellitus in South African Indians: a 10‐year follow‐up study

Ayesha A. Motala, Fraser Pirie, Eleanor Gouws et al. · Diabetic Medicine · 2003 · 66 citations

Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by <scp>GLP‐1RA</scp> treatment: A subgroup analysis from the <scp>FIDELIO‐DKD</scp> trial

Peter Rossing, Rajiv Agarwal, Stefan D. Anker et al. · Diabetes Obesity and Metabolism · 2021 · 61 citations · Full text

Microvascular complications in South African patients with long-duration diabetes mellitus.

Ayesha A. Motala, Fraser Pirie, Eleanor Gouws et al. · PubMed · 2001 · 58 citations

1–5 of 13